Pulegone

CAS No. 89-82-7

Pulegone( Pulegone | NSC 15334 | NSC15334 | D-Pulegone )

Catalog No. M19240 CAS No. 89-82-7

Pulegone has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 29 In Stock

Biological Information

  • Product Name
    Pulegone
  • Note
    Research use only, not for human use.
  • Brief Description
    Pulegone has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats.
  • Description
    Pulegone has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats. Pulegone induces a verapamil-sensitive psychostimulant effect that appears to independ on the opening of L-type calcium channels. Pulegone has negative reinforcing properties and seems to possess anxiolytic-like actions unrelated to the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Pulegone | NSC 15334 | NSC15334 | D-Pulegone
  • Pathway
    Tyrosine Kinase
  • Target
    Src
  • Recptor
    L-type calcium channel
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    89-82-7
  • Formula Weight
    152.23
  • Molecular Formula
    C10H16O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 270 mg/mL (1773.63 m)
  • SMILES
    CC1CCC(=C(C)C)C(=O)C1
  • Chemical Name
    Cyclohexanone, 5-methyl-2-(1-methylethylidene)-, (R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • eCF506

    eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?

  • CSF1R-IN-2

    CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).

  • DGY-06-116

    DGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.